We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
PRFT | Perficient Inc | 73.50 | 25.39 | 52.77% | 25,429 |
BENF | Beneficient | 9.02 | 2.20 | 32.26% | 1,337,860 |
ASUR | Asure Software Inc | 9.00 | 1.96 | 27.84% | 1 |
NUVO | Holdco Nuvo Group DG Ltd | 2.60 | 0.56 | 27.45% | 558,825 |
OMH | Ohmyhome Ltd | 0.705 | 0.141 | 25.00% | 1,307,727 |
DPCS | DP Cap Acquisition Corporation I | 13.81 | 2.62 | 23.42% | 866 |
BMRA | Biomerica Inc | 0.6787 | 0.1187 | 21.20% | 21 |
CMPX | Compass Therapeutics Inc | 2.04 | 0.34 | 20.00% | 1 |
IKT | Inhibikase Therapeutics Inc | 1.64 | 0.25 | 17.99% | 3 |
CDTG | CDT Environmental Technology Investment Holdings Ltd | 3.97 | 0.58 | 17.11% | 188 |
ATNF | 180 Life Sciences Corporation | 2.32 | 0.32 | 16.00% | 4 |
Perficient, Inc. (Nasdaq: PRFT) (“Perficient”), the leading global digital consultancy transforming the world’s largest enterprises and biggest brands, today reported its financial results for the quarter ended March 31, 2024.
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced the publication of its TORREY Phase 2 study manuscript in the Lancet Respiratory Medicine journal. The paper, titled "Seralutinib in Adults with Pulmonary Arterial Hypertension (TORREY): A Randomized, Double-blind, Placebo-controlled Phase 2 Trial," details the study's significant findings in advancing the treatment of PAH.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 64,101.54 | 102.46 | 0.16% | 1.26T | 2,670,174,380 |
ETH | Ethereum | 3,147.79 | 11.44 | 0.36% | 377.88B | 1,442,333,806 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 138,219,865 |
BNB | Binance Coin | 589.16 | -2.64 | -0.45% | 92.92B | 152,404,686 |
SOL | Solana | 152.74 | 7.09 | 4.87% | 67.19B | 639,956,070 |
STETH | stETH | 3,132.00 | -3.41 | -0.11% | 30.85B | 5,319,117 |
XRP | Ripple | 0.5348 | 0.0051 | 0.96% | 29.12B | 157,291,217 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 414,372,450 |
DOGE | Dogecoin | 0.1617 | 0.00072 | 0.45% | 23.06B | 455,365,014 |
TONCOIN | Wrapped TON Coin | 5.96 | -0.007594 | -0.13% | 20.66B | 93,807,307 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions